Rare genetic disorder points to molecules that may play role in schizophrenia — Finding may suggest novel therapeutic target for treating disease – Scientists studying a rare genetic disorder have identified a molecular pathway that may play a role in schizophrenia. The findings may one day guide researchers to new treatment options for people with schizophrenia ? a devastating disease that affects approximately 1 percent of the world’s population.
Caffeine may block inflammation linked to mild cognitive impairment – Recent studies have linked caffeine consumption to a reduced risk of Alzheimer’s disease, and a new University of Illinois study may be able to explain how this happens. Researchers have discovered a novel signal that activates the brain-based inflammation associated with neurodegenerative diseases, and caffeine appears to block its activity.
Chewing ability linked to reduced dementia risk — Can you bite into an apple? If so, you are more likely to maintain mental abilities. – Can you bite into an apple? If so, you are more likely to maintain mental abilities, according to new research from Karolinska Institutet. The population is ageing, and the older we become the more likely it is that we risk deterioration of our cognitive functions, such as memory, decision-making and problem solving.
Exercise improves memory, thinking after stroke, study finds – Just six months of exercise can improve memory, language, thinking and judgment problems by almost 50 per cent. Toronto researchers found that the proportion of stroke patients with at least mild cognitive impairment dropped from 66 per cent to 37 per cent during a research study on the impact of exercise on the brain.
Binge drinking increases the risk of cognitive decline in older adults – Researchers from the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, suggesting a link between binge drinking in older adults and the risk of developing dementia. The work is supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care in the South West Peninsula (NIHR PenCLAHRC).
First detailed timeline established for brain’s descent into Alzheimer’s – Scientists have assembled the most detailed chronology to date of the human brain’s long, slow slide into full-blown Alzheimer’s disease. As part of an international research partnership known as the Dominantly Inherited Alzheimer’s Network (DIAN), scientists at Washington University and elsewhere evaluated a variety of pre-symptomatic markers of Alzheimer’s disease in 128 subjects from families genetically predisposed to develop the disorder.
FDA approves Belviq to treat some overweight or obese adults – Belviq (lorcaserin hydrochloride) is approved as an addition to a reduced-calorie diet and exercise, for chronic weight management. This obesity drug is approved by US FDA for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
Learn that tune while fast asleep — Research shows that stimulation during sleep can enhance skill learning – Want to nail that tune that you’ve practiced and practiced? Maybe you should take a nap with the same melody playing during your sleep, new provocative Northwestern University research suggests. The research grows out of exciting existing evidence that suggests that memories can be reactivated during sleep and storage of them can be strengthened in the process.
Stress link to Alzheimer’s goes under the spotlight — A new ?1.5 million study to find role of stress in development of dementia and Alzheimer’s disease – Chronic stress is being investigated in a new Alzheimer’s Society funded research project as a risk factor for developing dementia. It is part of a ?1.5 million package of six grants being given by the charity fighting to find a cause, cure and way to prevent the disease.
Role of omega-3 in preventing cognitive decline in older people questioned — Elderly warned that taking fish oil pills ‘does not prevent brain decline’ – Older people who take omega-3 fish oil supplements are probably not reducing their chances of losing cognitive function. Based on the available data from studies lasting up to 3.5 years, the researchers concluded that the supplements offered no benefits for cognitive health over placebo capsules or margarines, but that longer term effects are worth investigating.
